Celltrion
Celltrion is a global biopharmaceutical company that researches, develops and manufactures antibody biosimilars and novel therapeutics. By successfully developing the world’s first monoclonal antibody biosimilar, Celltrion has opened new frontiers in the biopharmaceutical industry, delivering advanced treatment options that improve the quality of life for patients worldwide. Leveraging world-class biotechnology and forward-looking business strategies, Celltrion continues to grow as a fully integrated biopharmaceutical leader, committed to enhancing health and well-being globally.